Levetiracetam Doc

Levetiracetam, the active ingredient in Levetiracetam Doc, is an anticonvulsant presented as an oral formulation for oral use. It is employed to treat various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures, and is marketed throughout the European Union.

GNH USA supplies Levetiracetam Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for global distribution. The company adheres to EU GMP standards.

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types. - Partial seizures: helps control focal onset seizures, reducing frequency and severity. - Generalized tonic-clonic seizures: provides seizure control for bilateral convulsive episodes. - Myoclonic seizures: diminishes rapid, brief muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit. - Irritability: mood changes or increased agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression, anxiety, or suicidal thoughts. - Hematologic abnormalities: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Stevens‑Johnson syndrome: severe skin blistering.

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure patient safety. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Psychiatric symptoms: watch for mood changes, depression, or suicidal ideation. - Concomitant alcohol use: advise patients to avoid alcohol, which may increase CNS effects. - Pregnancy: discuss potential risks with the prescriber, as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, reducing levetiracetam plasma levels. - Phenytoin: enzyme induction may lower levetiracetam concentrations. - Phenobarbital: may decrease levetiracetam exposure through increased clearance.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may enhance sedation or dizziness. - Alcohol: can potentiate central nervous system effects. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, requiring alternative contraception.